Cost-Effectiveness of Next-Generation Sequencing Versus Single-Gene Testing for the Molecular Diagnosis of Patients With Metastatic Non-Small-Cell Lung Cancer From the Perspective of Spanish Reference Centers.
Edurne ArriolaReyes BernabéRosario García CampeloMichele BiscuolaAna Belén EnguitaFernando López-RíosRafael MartínezLaura MezquitaSarai Palanca SuelaMaría Jesús ParejaJon ZugazagoitiaNatalia ArrabalJ Francisco GarcíaDavid CarcedoEnrique de ÁlavaPublished in: JCO precision oncology (2023)
Using NGS in Spanish reference centers for the molecular diagnosis of patients with metastatic NSCLC would be a cost-effective strategy over SgT.